1. Home
  2. BFAM vs ROIV Comparison

BFAM vs ROIV Comparison

Compare BFAM & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bright Horizons Family Solutions Inc.

BFAM

Bright Horizons Family Solutions Inc.

HOLD

Current Price

$101.22

Market Cap

5.5B

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$22.21

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFAM
ROIV
Founded
1986
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
14.1B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
BFAM
ROIV
Price
$101.22
$22.21
Analyst Decision
Buy
Strong Buy
Analyst Count
6
8
Target Price
$130.67
$24.31
AVG Volume (30 Days)
668.3K
8.2M
Earning Date
02-12-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
72.95
N/A
EPS
3.47
N/A
Revenue
$2,874,055,000.00
$20,329,000.00
Revenue This Year
$11.17
N/A
Revenue Next Year
$6.80
$741.42
P/E Ratio
$29.24
N/A
Revenue Growth
9.38
N/A
52 Week Low
$91.49
$8.73
52 Week High
$132.99
$23.47

Technical Indicators

Market Signals
Indicator
BFAM
ROIV
Relative Strength Index (RSI) 49.09 58.09
Support Level $99.11 $21.60
Resistance Level $105.57 $22.72
Average True Range (ATR) 2.39 0.82
MACD -0.14 -0.00
Stochastic Oscillator 47.21 61.77

Price Performance

Historical Comparison
BFAM
ROIV

About BFAM Bright Horizons Family Solutions Inc.

Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; full-service center-based child care, backup care, and educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: